News
TB can be cured, but ridding the body of the bug often takes many months and usually requires taking four or more medicines. In this special briefing, Spotlight zooms in on what makes the TB bacterium ...
The study explored the challenges to the undertaking and growth of security and strategic studies (SSS) in Africa. This was against the observed increased establishment of SSS courses in both African ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
17hon MSN
Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of ...
7h
Zacks Investment Research on MSNMerck Starts Phase III Studies on Once-Monthly Pill for HIV PreventionMerck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results